Authors:
Cremerius, U
Fabry, U
Neuerburg, J
Zimny, M
Bares, R
Osieka, R
Bull, U
Citation: U. Cremerius et al., Prognostic significance of positron emission tomography using fluorine-18-fluorodeoxyglucose in patients treated for malignant lymphoma, NUKLEARMED, 40(1), 2001, pp. 23-30
Authors:
Di Martino, E
Nowak, B
Krombach, GA
Seilhaus, B
Hausmann, R
Cremerius, U
Bull, U
Westhofen, M
Citation: E. Di Martino et al., Results of pretherapeutic lymph node diagnosis in head and neck cancer: Clinical value of (18)-fluorodeoxyglucose positron emission tomography (PET)., LARY RH OTO, 79(4), 2000, pp. 201-206
Authors:
Reinartz, P
Schaffeldt, J
Sabri, O
Zimny, M
Nowak, B
Ostwald, E
Cremerius, U
Buell, U
Citation: P. Reinartz et al., Benign versus malignant osseous lesions in the lumbar vertebrae: differentiation by means of bone SPET, EUR J NUCL, 27(6), 2000, pp. 721-726
Authors:
Zimny, M
Fass, J
Bares, R
Cremerius, U
Sabri, O
Buechin, P
Schumpelick, V
Buell, U
Citation: M. Zimny et al., Fluorodeoxyglucose positron emission tomography and the prognosis of pancreatic carcinoma, SC J GASTR, 35(8), 2000, pp. 883-888
Authors:
Nowak, B
Di Martino, E
Janicke, S
Cremerius, U
Adam, G
Zimny, M
Reinartz, P
Bull, U
Citation: B. Nowak et al., Diagnostic evaluation of malignant head and neck cancer by F-18-FDG PET compared to CT/MRI, NUKLEARMED, 38(8), 1999, pp. 312-318
Authors:
Ostwald, E
Sabri, O
Cremerius, U
Jakse, G
Bull, U
Citation: E. Ostwald et al., Follow-up bone scintigraphy and rhenium application during therapy of a prostate cancer, NUKLEARMED, 38(7), 1999, pp. 302-305
Authors:
Reinartz, P
Zimny, M
Cremerius, U
Sabri, O
Kaiser, HJ
Nowak, B
Bull, U
Citation: P. Reinartz et al., Quantification of repositioning errors in PET-studies through superposition of emission and transmission scan - A comparison between one-step and two-step acquisitions, NUKLEARMED, 38(6), 1999, pp. 192-198
Authors:
Zimny, M
Kaiser, HJ
Cremerius, U
Sabri, O
Schreckenberger, M
Reinartz, P
Bull, U
Citation: M. Zimny et al., F-18-FDG positron imaging in oncological patients: Gamma camera coincidence detection versus dedicated PET, NUKLEARMED, 38(4), 1999, pp. 108-114
Authors:
Cremerius, U
Fabry, U
Kroll, U
Zimny, M
Neuerburg, J
Osieka, R
Bull, U
Citation: U. Cremerius et al., Clinical value of FDG-PET for therapy monitoring of malignant lymphoma - Results of a retrospective study in 72 patients, NUKLEARMED, 38(1), 1999, pp. 24-30
Authors:
Young, H
Baum, R
Cremerius, U
Herholz, K
Hoekstra, O
Lammertsma, AA
Pruim, J
Price, P
Citation: H. Young et al., Measurement of clinical and subclinical tumour response using [F-18]-fluorodeoxyglucose and positron emission tomography: Review and 1999 EORTC recommendations, EUR J CANC, 35(13), 1999, pp. 1773-1782
Authors:
Zimny, M
Kaiser, HJ
Cremerius, U
Reinartz, P
Schreckenberger, M
Sabri, O
Buell, U
Citation: M. Zimny et al., Dual-head gamma camera 2-[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography in oncological patients: effects of non-uniform attenuation correction on lesion detection, EUR J NUCL, 26(8), 1999, pp. 818-823
Authors:
Grunwald, F
Kalicke, T
Feine, U
Lietzenmayer, R
Scheidhauer, K
Dietlein, M
Schober, O
Lerch, H
Brandt-Mainz, K
Burchert, W
Hiltermann, G
Cremerius, U
Biersack, HJ
Citation: F. Grunwald et al., Fluorine-18 fluorodeoxyglucose positron emission tomography in thyroid cancer: results of a multicentre study, EUR J NUCL, 26(12), 1999, pp. 1547-1552
Authors:
Cremerius, U
Wildberger, JE
Borchers, H
Zimny, M
Jakse, G
Gunther, RW
Buell, U
Citation: U. Cremerius et al., Does positron emission tomography using 18-fluoro-2-deoxyglucose improve clinical staging of testicular cancer? - Results of a study in 50 patients, UROLOGY, 54(5), 1999, pp. 900-904
Authors:
Cremerius, U
Fabry, U
Neuerburg, J
Zimny, M
Osieka, R
Buell, U
Citation: U. Cremerius et al., Positron emission tomography with F-18-FDG to detect residual disease after therapy for malignant lymphoma, NUCL MED C, 19(11), 1998, pp. 1055-1063